CN1309553A - 生物活性组合物 - Google Patents

生物活性组合物 Download PDF

Info

Publication number
CN1309553A
CN1309553A CN99808547A CN99808547A CN1309553A CN 1309553 A CN1309553 A CN 1309553A CN 99808547 A CN99808547 A CN 99808547A CN 99808547 A CN99808547 A CN 99808547A CN 1309553 A CN1309553 A CN 1309553A
Authority
CN
China
Prior art keywords
compositions
bioactive agents
carrier
biologically active
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99808547A
Other languages
English (en)
Chinese (zh)
Inventor
A·林达尔
C·本纳迪森
H·哈格斯特莱特
R·布赖兰德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioglan AB
Original Assignee
Bioglan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan AB filed Critical Bioglan AB
Publication of CN1309553A publication Critical patent/CN1309553A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN99808547A 1998-05-14 1999-05-12 生物活性组合物 Pending CN1309553A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801704-9 1998-05-14
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition

Publications (1)

Publication Number Publication Date
CN1309553A true CN1309553A (zh) 2001-08-22

Family

ID=20411318

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99808547A Pending CN1309553A (zh) 1998-05-14 1999-05-12 生物活性组合物

Country Status (20)

Country Link
US (1) US6537576B1 (https=)
EP (1) EP1082102B1 (https=)
JP (1) JP2002514587A (https=)
KR (1) KR100592971B1 (https=)
CN (1) CN1309553A (https=)
AT (1) ATE310500T1 (https=)
AU (1) AU736480B2 (https=)
CA (1) CA2331527C (https=)
DE (2) DE1082102T1 (https=)
ES (1) ES2155048T3 (https=)
GR (1) GR20010300013T1 (https=)
HU (1) HUP0102426A2 (https=)
IL (2) IL139576A0 (https=)
NO (1) NO20005724L (https=)
NZ (1) NZ508073A (https=)
PL (1) PL344051A1 (https=)
SE (1) SE9801704D0 (https=)
TR (1) TR200003589T2 (https=)
WO (1) WO1999058108A1 (https=)
ZA (1) ZA200006474B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003524652A (ja) * 2000-02-29 2003-08-19 ツァン，ツィエ 改良された経皮薬剤パッチ
KR20090031726A (ko) 2006-06-14 2009-03-27 닥터 레디스 레보러터리즈 리미티드 국소용 조성물
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
EP2349230A2 (en) 2008-10-06 2011-08-03 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
EP3473615B1 (en) 2013-02-28 2022-01-19 Journey Medical Corporation Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
IL139576A0 (en) 2002-02-10
JP2002514587A (ja) 2002-05-21
AU736480B2 (en) 2001-07-26
ZA200006474B (en) 2001-09-04
TR200003589T2 (tr) 2001-03-21
KR20010052348A (ko) 2001-06-25
DE1082102T1 (de) 2001-09-06
EP1082102B1 (en) 2005-11-23
DE69928524T2 (de) 2006-08-10
DE69928524D1 (de) 2005-12-29
SE9801704D0 (sv) 1998-05-14
PL344051A1 (en) 2001-09-24
ES2155048T1 (es) 2001-05-01
NZ508073A (en) 2002-12-20
WO1999058108A1 (en) 1999-11-18
ES2155048T3 (es) 2006-06-16
NO20005724L (no) 2001-01-09
IL139576A (en) 2007-07-04
KR100592971B1 (ko) 2006-06-23
CA2331527C (en) 2010-04-13
US6537576B1 (en) 2003-03-25
HUP0102426A2 (hu) 2002-03-28
GR20010300013T1 (en) 2001-04-30
EP1082102A1 (en) 2001-03-14
CA2331527A1 (en) 1999-11-18
NO20005724D0 (no) 2000-11-13
ATE310500T1 (de) 2005-12-15
AU4405099A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
EP1510213B1 (en) Penetration enhancing and irritation reducing systems comprising testosterone
CN1048322A (zh) 表面凝胶配方和粉刺的治疗方法
CN1407898A (zh) 具有全身效应的新型局部雌激素孕激素组合物
JPH02131426A (ja) ブナゾシン或いはその塩類含有経皮適用製剤
CN1309553A (zh) 生物活性组合物
WO1995004551A1 (en) Percutaneously absorbable preparation
JP2001302690A (ja) 皮膚浸透性トリペプチド、皮膚浸透性コラーゲンペプチド、皮膚浸透性外用剤および高吸収性食品
EP1077677B1 (en) Process for the manufacture of a biologically active composition
WO2008047857A1 (fr) Procédé de production d'une composition comprenant un composé difficilement soluble dans l'eau incorporé dans une matrice hydrophile et préparation pour une utilisation externe comprenant un agent ou médicament anticancéreux ayant un coefficient de partage octanol/eau (log p) de -3,0 ou plus mais pas plus de 3,0, incorporé
MXPA00011077A (en) Biologically active composition
MXPA00011082A (en) Biologically active composition
JPH02124824A (ja) アゼラスチン或いはその塩類含有経皮適用製剤
WO1992020376A1 (fr) Composition de promoteur de l'absorption percutanee et preparation externe pour l'administration de medicaments par voie percutanee
JPH0764734B2 (ja) 経皮投与製剤
CZ20004127A3 (cs) Biologicky aktivní prostředek a způsob jeho přípravy
CZ20004128A3 (cs) Biologicky aktivní prostředek a způsob jeho přípravy
CN121129757A (zh) 一种丙酸氯倍他索搽剂及其制备方法
JP2003160489A (ja) オンダンセトロン経皮吸収用医薬組成物
JP3026330B2 (ja) アゼラスチン或いはその塩類含有経皮適用製剤
JP2005132753A (ja) 外皮用医薬組成物
HK1074788A1 (en) Penetration enhancing and irritation reducing systems comprising testosterone
HK1074788B (en) Penetration enhancing and irritation reducing systems comprising testosterone
JPWO2000053226A1 (ja) 経皮吸収促進組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication